XML 63 R51.htm IDEA: XBRL DOCUMENT v3.25.1
Inventory - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Dec. 31, 2024
[1]
Inventory [Line Items]    
Inventories - current $ 63,975 $ 58,872
Inventories-noncurrent 365,311 $ 348,327
Inventory incurred prior to FDA approval $ 27,700  
Minimum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 4 months  
Maximum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 38 months  
[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date.